The fact that changes in CB1 expression are structure-specific, led us to speculate that our data may help to explain the participation of the cannabinoid system in a possible compensatory mechanism in PD, possibly related to neuronal plasticity. This evidence concerns the gene CNR1 and Parkinson disease.